Currently, there are 225.00M common shares owned by the public and among those 216.49M shares have been available to trade.
The company’s stock has a 5-day price change of 0.74% and -0.28% over the past three months. BBWI shares are trading -26.99% year to date (YTD), with the 12-month market performance up to 2.40% higher. It has a 12-month low price of $26.20 and touched a high of $52.99 over the same period. BBWI has an average intraday trading volume of 5.66 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.30%, 4.95%, and -20.14% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bath & Body Works Inc (NYSE: BBWI) shares accounts for 99.69% of the company’s 225.00M shares outstanding.
It has a market capitalization of $6.52B and a beta (3y monthly) value of 1.78. The stock’s trailing 12-month PE ratio is 7.61, while the earnings-per-share (ttm) stands at $4.14. The company has a PEG of 0.63 and a Quick Ratio of 0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.84% over the week and 3.88% over the month.
Earnings per share for the fiscal year are expected to decrease by -2.09%, and 10.81% over the next financial year.
Looking at the support for the BBWI, a number of firms have released research notes about the stock. Barclays stated their Underweight rating for the stock in a research note on November 08, 2024, with the firm’s price target at $31-$28. Telsey Advisory Group coverage for the Bath & Body Works Inc (BBWI) stock in a research note released on August 29, 2024 offered a Outperform rating with a price target of $42. JP Morgan was of a view on May 17, 2024 that the stock is Neutral, while Telsey Advisory Group gave the stock Outperform rating on March 01, 2024, issuing a price target of $50- $53. Barclays on their part issued Equal Weight rating on January 04, 2024.
